Agilent Technologies Intrinsic Value Calculation – AGILENT TECHNOLOGIES Reports Third Quarter FY2023 Earnings Results

🌥️Earnings Overview

On August 15 2023, AGILENT TECHNOLOGIES ($NYSE:A) announced its financial results for the third quarter of the fiscal year 2023 that concluded on July 31 2023. The company’s total revenue for the quarter was USD 1672.0 million, a dip of 2.7% compared to the same period of the previous year. Net income for this quarter was USD 111.0 million, which is a considerable decrease of 66.3% from the same quarter of the prior year.

Share Price

On Tuesday, AGILENT TECHNOLOGIES reported its third-quarter earnings results for FY2023. The stock opened at $126.3 and closed at $125.6, down by 0.8% from the previous closing price of 126.6. This marks the fourth consecutive quarter that the stock has posted year-over-year declines in earnings. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Agilent Technologies. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Agilent Technologies. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Agilent Technologies. More…

Key Ratios Snapshot

Some of the financial key ratios for Agilent Technologies are shown below. More…

Analysis – Agilent Technologies Intrinsic Value Calculation

At GoodWhale, we have conducted an in-depth analysis of AGILENT TECHNOLOGIES’s fundamentals and have come to the conclusion that its intrinsic value is at around $151.3, according to our proprietary Valuation Line. The current stock price of AGILENT TECHNOLOGIES is $125.6, which is a fair price, but is undervalued by 17.0%. We recommend that investors who are looking to capitalize on this opportunity should do so as soon as possible as the undervaluation of AGILENT TECHNOLOGIES is likely to not remain this low for long. More…

Peers

The company has a strong presence in the market and competes with Qiagen NV, Thermo Fisher Scientific Inc, Illumina Inc, and other companies. Agilent Technologies Inc. is committed to providing innovative products and services that meet the needs of customers and enable them to achieve their research goals.

– Qiagen NV ($NYSE:QGEN)

Qiagen is a Dutch company that provides molecular diagnostic solutions, including kits and instruments for sample preparation and real-time PCR. The company has a market cap of 9.99B as of 2022 and a ROE of 13.07%.

– Thermo Fisher Scientific Inc ($NYSE:TMO)

Thermo Fisher Scientific Inc is a biotechnology company that manufactures and sells scientific instruments, reagents, and laboratory products. The company has a market capitalization of 201.37 billion as of 2022 and a return on equity of 12.43%. Thermo Fisher Scientific is a global leader in serving science, with revenues of more than $30 billion and a workforce of more than 70,000 employees. The company’s mission is to enable its customers to make the world healthier, cleaner, and safer.

– Illumina Inc ($NASDAQ:ILMN)

Illumina Inc. is an American company headquartered in San Diego, California. It is a provider of sequencing and array-based solutions for genetic analysis. The company has a market cap of $36.65 billion as of 2022 and a return on equity of 0.28%. Illumina’s products are used by academic and commercial researchers in a variety of fields, including cancer, infectious disease, genetics, and more.

Summary

AGILENT TECHNOLOGIES reported its third quarter earnings for FY2023, ending on July 31 2023, on August 15 2023. Total revenue for the quarter was USD 1672.0 million, a decrease of 2.7% year over year, and net income was USD 111.0 million, a 66.3% drop from the prior year. Investors should note that AGILENT TECHNOLOGIES has experienced a decline in revenue and income, indicating a potential long-term trend of decreasing performance. Nevertheless, investors should consider the company’s balance sheet, free cash flow, management team and competitive environment when making an investment decision.